Address
25 Norman Way
Cambridge, CB24 5QE
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1223 967 943
Website
Sector
Healthcare
Industry
Biotechnology
Employees
101
First IPO Date
February 17, 2021
| Name | Title | Pay | Year Born |
| Amy Walker | CEO & Director | 339,000 | 1993 |
| Manja Hermina Elisabeth Maria Boerman | Executive Chair of the Board | 63,400 | 1966 |
| Scott Lorimer | Chief Operating Officer | 0 | N/A |
| Christine Wolosin | Chief Commercial Officer | 0 | N/A |
| Jennifer Gelman | Vice President of Marketing | 0 | N/A |
4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.